| Nov 8 |
TruBridge (TBRG) Reports Q3 Loss, Tops Revenue Estimates
|
| Nov 7 |
Fulgent Genetics Q3 2024 Earnings Preview
|
| Nov 5 |
Fulgent to Participate in Upcoming Conferences
|
| Nov 1 |
Fulgent Genetics (FLGT) Surges 5.8%: Is This an Indication of Further Gains?
|
| Oct 31 |
Fulgent Genetics Awarded Contract by the U.S. Department of Veterans Affairs to Provide Hereditary Cancer, Pharmacogenetic and Other Genetic Testing to Veterans1
|
| Oct 17 |
Fulgent to Announce Third Quarter 2024 Financial Results on Friday, November 8, 2024
|
| Oct 8 |
Hims & Hers Health (HIMS) Soars 10.1%: Is Further Upside Left in the Stock?
|
| Sep 25 |
Fulgent Genetics: An NCAV Pick With Profit And Growth Potential
|
| Sep 18 |
Those who invested in Fulgent Genetics (NASDAQ:FLGT) five years ago are up 107%
|
| Sep 9 |
Fulgent Genetics: Core Growth Re-Acceleration Will Be The Critical Catalyst
|
